Variant report
Variant | rs6601582 |
---|---|
Chromosome Location | chr8:11207367-11207368 |
allele | A/C |
Outlinks | Ensembl   UCSC |
- TF binding region (count:3)
- CpG islands (count:0)
- Chromatin interactive region (count:6)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:3 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | JUN | chr8:11207245-11208706 | K562 | blood: | n/a | chr8:11207916-11207924 chr8:11207914-11207926 chr8:11207962-11207973 |
2 | GATA1 | chr8:11206280-11208770 | K562 | blood: | n/a | chr8:11207984-11207996 chr8:11208096-11208106 |
3 | EP300 | chr8:11207015-11208357 | SK-N-SH | brain: | n/a | chr8:11208121-11208131 |
No data |
(count:6 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr8:11202674..11205995-chr8:11206285..11210798,7 | K562 | blood: | |
2 | chr8:11141950..11143471-chr8:11205387..11207796,2 | K562 | blood: | |
3 | chr8:11202670..11208385-chr8:11211112..11215163,10 | K562 | blood: | |
4 | chr8:11205483..11207435-chr8:11216914..11218469,2 | MCF-7 | breast: | |
5 | chr8:11140914..11143471-chr8:11206296..11209213,2 | K562 | blood: | |
6 | chr8:11205933..11210781-chr8:11211287..11215199,6 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000255020 | TF binding region |
ENSG00000104643 | Chromatin interaction |
ENSG00000154316 | Chromatin interaction |
ENSG00000255020 | Chromatin interaction |
rs_ID | r2[population] |
---|---|
rs10096194 | 0.83[CEU][hapmap] |
rs10098322 | 0.81[CEU][hapmap] |
rs10110557 | 0.86[CEU][hapmap] |
rs1047950 | 0.89[CEU][hapmap];0.85[AMR][1000 genomes];0.87[EUR][1000 genomes] |
rs10503421 | 0.86[CEU][hapmap];0.82[AMR][1000 genomes] |
rs11250130 | 0.81[CEU][hapmap];0.82[EUR][1000 genomes] |
rs11777746 | 1.00[AMR][1000 genomes];0.99[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs11781637 | 0.81[CEU][hapmap];0.82[EUR][1000 genomes] |
rs11782430 | 0.82[AMR][1000 genomes] |
rs12681987 | 0.96[CEU][hapmap];1.00[JPT][hapmap] |
rs13260727 | 0.82[CEU][hapmap] |
rs1435277 | 0.88[CEU][hapmap];0.88[AMR][1000 genomes];0.92[EUR][1000 genomes] |
rs17741537 | 0.85[CEU][hapmap] |
rs17797894 | 0.82[CEU][hapmap] |
rs2043510 | 0.82[AMR][1000 genomes] |
rs2060456 | 0.85[CEU][hapmap] |
rs2060457 | 0.81[CEU][hapmap] |
rs2060459 | 0.85[CEU][hapmap] |
rs2246606 | 0.85[CEU][hapmap];0.84[AMR][1000 genomes];0.85[EUR][1000 genomes] |
rs2249804 | 0.81[CEU][hapmap];0.88[AMR][1000 genomes];0.88[EUR][1000 genomes] |
rs2250028 | 0.81[CEU][hapmap];0.88[AMR][1000 genomes];0.88[EUR][1000 genomes] |
rs2293859 | 0.89[CEU][hapmap] |
rs2293860 | 0.85[CEU][hapmap] |
rs2409756 | 0.82[CEU][hapmap] |
rs2572371 | 0.92[CEU][hapmap];0.85[AMR][1000 genomes] |
rs2572382 | 0.93[CEU][hapmap];0.90[AMR][1000 genomes];0.93[EUR][1000 genomes] |
rs2572385 | 0.92[CEU][hapmap];0.89[AMR][1000 genomes];0.95[EUR][1000 genomes] |
rs2572386 | 0.82[CEU][hapmap] |
rs2572387 | 0.94[AMR][1000 genomes];0.98[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs2572404 | 0.81[AMR][1000 genomes];0.88[EUR][1000 genomes] |
rs2572452 | 0.96[CEU][hapmap];0.81[AMR][1000 genomes] |
rs2736264 | 0.85[AMR][1000 genomes];0.89[EUR][1000 genomes] |
rs2736265 | 0.90[AMR][1000 genomes];0.92[EUR][1000 genomes];0.83[ASN][1000 genomes] |
rs2736266 | 0.83[EUR][1000 genomes] |
rs2736270 | 0.91[CEU][hapmap];0.85[AMR][1000 genomes];0.91[EUR][1000 genomes] |
rs2736273 | 0.88[AMR][1000 genomes];0.94[EUR][1000 genomes] |
rs2736278 | 0.84[AMR][1000 genomes];0.83[EUR][1000 genomes] |
rs2736280 | 0.92[CEU][hapmap];0.83[AMR][1000 genomes];0.80[EUR][1000 genomes] |
rs2736282 | 0.88[CEU][hapmap];0.81[AMR][1000 genomes] |
rs2736283 | 0.88[CEU][hapmap];0.82[AMR][1000 genomes] |
rs2736286 | 0.81[AMR][1000 genomes] |
rs2736287 | 0.80[AMR][1000 genomes] |
rs2736288 | 0.83[CEU][hapmap] |
rs2736290 | 0.81[CEU][hapmap] |
rs2736292 | 0.82[CEU][hapmap] |
rs2736295 | 0.82[CEU][hapmap] |
rs35418978 | 0.85[AMR][1000 genomes];0.89[EUR][1000 genomes] |
rs3779891 | 0.85[CEU][hapmap] |
rs4363158 | 0.83[AMR][1000 genomes];0.85[EUR][1000 genomes] |
rs4413734 | 0.85[CEU][hapmap] |
rs5029571 | 0.85[CEU][hapmap] |
rs6601585 | 0.83[CEU][hapmap] |
rs6995404 | 0.81[CEU][hapmap] |
rs7005469 | 0.81[CEU][hapmap] |
rs7016671 | 0.81[CEU][hapmap] |
rs7816606 | 0.97[AMR][1000 genomes];0.98[EUR][1000 genomes];0.87[ASN][1000 genomes] |
rs7819395 | 0.86[CEU][hapmap] |
rs7820301 | 0.81[AMR][1000 genomes] |
rs7838897 | 0.86[CEU][hapmap] |
rs7839053 | 0.86[CEU][hapmap] |
rs7839307 | 0.81[AMR][1000 genomes];0.88[EUR][1000 genomes] |
rs920044 | 0.83[AMR][1000 genomes] |
rs978149 | 1.00[JPT][hapmap] |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | nsv1035072 | chr8:10819444-11480692 | Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Weak transcription Strong transcription Flanking Active TSS Bivalent/Poised TSS Active TSS Genic enhancers ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 50 gene(s) | inside rSNPs | diseases |
2 | nsv539473 | chr8:10819444-11480692 | Weak transcription Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Bivalent/Poised TSS Strong transcription Genic enhancers Flanking Bivalent TSS/Enh ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 50 gene(s) | inside rSNPs | diseases |
3 | nsv529399 | chr8:10970091-11805960 | Enhancers Strong transcription Weak transcription Bivalent Enhancer Genic enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS ZNF genes & repeats Transcr. at gene 5' and 3' Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 54 gene(s) | inside rSNPs | diseases |
4 | nsv831233 | chr8:11046854-11234384 | Weak transcription Enhancers Bivalent/Poised TSS Flanking Active TSS Strong transcription Active TSS Flanking Bivalent TSS/Enh ZNF genes & repeats Genic enhancers Bivalent Enhancer Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 17 gene(s) | inside rSNPs | diseases |
5 | nsv1022525 | chr8:11066191-11309356 | Enhancers Genic enhancers Weak transcription Strong transcription ZNF genes & repeats Flanking Active TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 19 gene(s) | inside rSNPs | diseases |
6 | nsv539474 | chr8:11066191-11309356 | Flanking Active TSS Weak transcription Enhancers Bivalent Enhancer Active TSS Strong transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats Genic enhancers Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 19 gene(s) | inside rSNPs | diseases |
7 | nsv1033312 | chr8:11126800-11252170 | Flanking Active TSS Weak transcription Strong transcription Bivalent/Poised TSS Bivalent Enhancer Enhancers Genic enhancers Active TSS ZNF genes & repeats Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 14 gene(s) | inside rSNPs | diseases |
8 | esv1821756 | chr8:11169178-11217587 | Weak transcription Flanking Active TSS Strong transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Active TSS ZNF genes & repeats Enhancers Genic enhancers Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 5 gene(s) | inside rSNPs | diseases |
9 | nsv890354 | chr8:11176147-11266131 | Bivalent Enhancer Strong transcription Weak transcription ZNF genes & repeats Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent/Poised TSS Enhancers Genic enhancers Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 8 gene(s) | inside rSNPs | diseases |
10 | esv34097 | chr8:11177372-11489894 | Weak transcription Flanking Active TSS Enhancers Strong transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Genic enhancers ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 17 gene(s) | inside rSNPs | diseases |
11 | nsv890355 | chr8:11202154-11219334 | Weak transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Active TSS ZNF genes & repeats Enhancers Transcr. at gene 5' and 3' Flanking Active TSS Genic enhancers Strong transcription | TF binding regionCpG islandChromatin interactive regionlncRNA | 3 gene(s) | inside rSNPs | diseases |
12 | nsv890356 | chr8:11202154-11223022 | Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS Weak transcription Bivalent Enhancer Strong transcription Genic enhancers Flanking Active TSS ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 4 gene(s) | inside rSNPs | diseases |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:11205600-11208400 | Flanking Active TSS | K562 | blood |
2 | chr8:11206200-11225000 | Weak transcription | Psoas Muscle | Psoas |
3 | chr8:11206400-11226400 | Weak transcription | Brain Anterior Caudate | brain |
4 | chr8:11207200-11207800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
5 | chr8:11207200-11207800 | Weak transcription | Pancreas | Pancrea |
6 | chr8:11207200-11223600 | Weak transcription | Brain Hippocampus Middle | brain |